News Quantified

TGTX – tg therapeutics, inc. (US:NASDAQ)

TG Therapeutics (NASDAQ:TGTX) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.

11/28

07:30 am

tgtx

Low

TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

TG Therapeutics (NASDAQ:TGTX) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.

TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies

TG Therapeutics: Positives From Q3'25 Earnings, But Competitors Progressing [Seeking Alpha]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}